Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01909674 · ClinicalTrials.gov registry record · NA
Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of OSA With CPAP
A NA study of Obstructive Sleep Apnea (OSA), sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01909674: Completed NA study of Obstructive Sleep Apnea (OSA), sponsored by Weill Medical College of Cornell University.
NCT01909674 is a NA study of Obstructive Sleep Apnea (OSA) that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 21 participants, below the 590-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01909674, a NA study of Obstructive Sleep Apnea (OSA), has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
Our group previously conducted a study looking at the performance of three styles of positive airway pressure masks during laboratory treatment studies for obstructive sleep apnea, and we found that patients using a full-mask mask required higher positive airway pressures than patients using nasal or nasal pillows style masks to achieve successful reduction of respiratory events. In the current study we want to randomly assign patients to either nasal or full-face masks and then switch to a different mask (if nasal was originally chosen than the mask will be switched to full-face and vise versa) after 3-weeks of use to see if the number of respiratory events change with the different mask style. We expect the number of respiratory events will increase with the use of full-face masks.
Primary Outcome
Total Sleep Time (TST) The amount of actually sleep time in a sleep episode; this time is equal to the total sleep episode less the awake time. TST is the total of all REM and NREM sleep in a sleep episode.
Conditions Studied
Interventions
- DEVICE Switch CPAP mask type
Study Locations (1)
New York
- Weill Cornell Center for Sleep Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01909674 record still lists
NCT01909674 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 590-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Obstructive Sleep Apnea (OSA) appearing as the primary indexed condition, and to 1 intervention - of which Switch CPAP mask type is the first listed.
NCT01909674 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01909674 about?
NCT01909674 is a clinical study titled "Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of OSA With CPAP". Our group previously conducted a study looking at the performance of three styles of positive airway pressure masks during laboratory treatment studies for obstructive sleep apnea, and we found that patients using a full-mask mask required higher positive airway pressures than patients using nasal o...
What is the current status of trial NCT01909674?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2011-09. Estimated completion is 2013-08.
What conditions does trial NCT01909674 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea (OSA).
What interventions are being tested in trial NCT01909674?
The interventions under investigation include: Switch CPAP mask type (DEVICE).
Who is sponsoring clinical trial NCT01909674?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01909674 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea (OSA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01909674's enrollment target sits among peer trials
21 10th of 12 higher than 3 of 12 other Obstructive Sleep Apnea (OSA) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea (OSA) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Circuit Rebreathing During CPAP Therapy
RECRUITING · NA
-
IOA Preventing Occlusal Changes With MAD Use
RECRUITING · NA
-
Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System
RECRUITING · NA
-
The Impact of Technology in Obstructive Sleep Apnea Myofunctional Therapy
ACTIVE NOT RECRUITING · NA
-
Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment
COMPLETED · NA
-
Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia